 |
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
|
U.S. Centers for Disease Control and Prevention
• International News
Aspen Pharmacare, Matrix to Set Up Venture
September 27, 2005 Aspen Pharmacare Holdings Ltd., South Africa's largest drug maker, and India's Matrix Laboratories Ltd. on Friday announced the establishment of a joint venture, called Astrix Laboratories Ltd., to manufacture generic AIDS drugs and other medications. Aspen will invest $36.5 million, and Matrix will transfer its manufacturing plant in Hyderabad, India, to Astrix. That factory currently makes antiretrovirals for the treatment of HIV/AIDS. In the transfer, expected to be completed by Jan. 1, Matrix will pass on the technology and intellectual property rights to some drugs made at the Hyderabad plant. Aspen and Matrix are among companies under contract to the William J. Clinton Foundation to supply low-cost AIDS drugs for the foundation's work in Africa. Back to other news for September 27, 2005 Associated Press 09.23.05 This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. |
|
